The physical principles for developing a synthetic lung surfactant to treat the respiratory distress syndrome are discussed. Requirements for the lipid composition and preparation of the synthetic surfactant are detailed, leading to the conclusion that a suspension of large unilamellar vesicles consisting of dipalmitoylphosphatidylcholine and a small amount of unsaturated lipid is a promising choice.